Webinar: Developing an Effective Regulatory Strategy for the Evolving 2024 Medtech Landsca... Online Del 22/10/2024 16:00 to 22/10/2024 Healthcare
The two research centres with ties to Hospital Clínic join the Barcelona Science Park 24/09/2024 Healthcare Access to innovation Talento The Barcelona Science Park of the University of Barcelona (UB) will host two new research centres with ties to Barcelona... Partners - Parc Científic de Barcelona
Vafidemstat emerges as a promising treatment for Borderline Personality Disorder 24/09/2024 Healthcare Advanced therapies Oryzon Genomics, a clinical-stage biopharmaceutical company, is advancing vafidemstat, its LSD1 inhibitor for CNS... Partners - Oryzon Genomics
Batea Oncology selected in the IMPACTO program from the Asociación Española Contra el Cánc... 24/09/2024 Healthcare The newly created company, based in Santiago de Compostela, has been one of the three awardees in the IMPACTO 2024... Partners - BATEA ONCOLOGY S.L.
BCN HEALTH presents three communications at the ISPOR Europe congress in Barcelona from 17... 24/09/2024 Healthcare BCN HEALTH, presents three different studies about the incidence and medical costs in prostate cancer, lupus and chronic... Partners - BCN Health
Revolutionary N·GENE, a pioneering solution that integrates genetics into the consultation... 24/09/2024 Healthcare Access to innovation Conceived as a research-only tool, it helps healthcare professionals enhance their practice through genetics. Partners - ADNTRO GENETICS SL
ORYZON presents the final data from PORTICO, a global Phase IIb vafidemstat trial in Borde... 23/09/2024 Healthcare Company presented the data to the FDA and discussed potential registrational Phase III vafidemstat study for the... Partners - Oryzon Genomics
AseBio highlights the main regulatory challenges faced by the Spanish biotechnology sector... 20/09/2024 Healthcare Access to innovation Innovative drugs Financing Sector-specific regulations, such as the revision of European pharmaceutical legislation, the IVDR and MDR Regulations... AseBio
Biotechnology plays a crucial role in the latest advances against Alzheimer's 21/09/2024 Healthcare Innovative drugs Personalized medicine Advanced therapies Biotechnology is behind every medication being tested and eventually approved, making its contribution the key factor... AseBio
Biotechnology plays a crucial role in the latest advances against Alzheimer's 21/09/2024 Nearly two decades ago, the first group of compounds to treat Alzheimer's disease were approved, but they do not stop... AseBio
